Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from QHSLab ( (USAQ) ).
On December 26, 2025, QHSLab raised approximately $500,000 in a private placement of common stock and warrants to two accredited investors, issuing about 1.67 million shares at $0.30 per share and 416,666 warrants exercisable at $0.60 through 2030, with net proceeds of more than $495,000 earmarked for general corporate purposes and working capital. Announced publicly on December 29, 2025, the financing followed the November 2025 repurchase and retirement of more than $1.4 million in high-cost legacy convertible notes, eliminating several million shares of potential dilution and over $200,000 in annual interest expense; together, the debt retirement and new equity capital materially improve QHSLab’s liquidity and capital structure, allowing management to shift focus toward scaling its digital health offerings, expanding its physician client base and driving recurring revenue growth, against a backdrop of 32% year-over-year revenue growth and a 66% gross margin for the first nine months of 2025.
Spark’s Take on USAQ Stock
According to Spark, TipRanks’ AI Analyst, USAQ is a Neutral.
USA Equities receives a modest score due to significant financial challenges, including negative equity and profitability issues, despite robust revenue growth and cash flow improvements. The mixed technical indicators and negative valuation metrics further weigh down the score. However, the score is bolstered by positive corporate events, including strategic partnerships and record revenue growth, highlighting potential for future success.
To see Spark’s full report on USAQ stock, click here.
More about QHSLab
QHSLab, Inc. (OTCQB: USAQ) is a digital health technology company that provides preventive screening, assessment and workflow solutions to primary care providers, helping medical practices identify, document and manage underdiagnosed chronic and behavioral health conditions more efficiently and profitably. The company focuses on digital medicine and population health innovation, including population and mental health tools, cognitive assessments, allergy diagnostics and other preventive care offerings.
Average Trading Volume: 14,351
Technical Sentiment Signal: Buy
Current Market Cap: $4.63M
Learn more about USAQ stock on TipRanks’ Stock Analysis page.